Today’s adjustment offers insight into what the next phase of the program is focusing on and will subsequently reward, and why this moment matters, especially for newer and regional plans. The post Medicare Advantage’s Big Decision: Reset or Retreat? appeared first on MedCity News.
Most recent settlement marks 14th enforcement action in OCR’s Risk Analysis Initiative
Through a new partnership, Marathon employer clients who don’t currently offer Lantern’s specialty care benefit can purchase it directly through Marathon. The post Lantern, Marathon Health Launch Partnership to Provide Integrated Primary and Specialty Care appeared first on MedCity News.
The policy could make it more difficult for states to obtain or renew Medicaid waivers
Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the way for Phase 3 testing. The post Kardigan’s IPO Lands $400M for Drugs That Get…
A recent JAMA editorial from two radiologists argues that elective whole-body MRI scan companies are misleading consumers about the benefits of said scans. The radiologists argue the MRIs are more likely to trigger harmful downstream procedures than they are to save lives. Not surprisingly, the three most prominent companies offering these scans denied the charge….
Healthcare organizations can leverage AI to identify at-risk members and facilitate ongoing human contact, emphasizing relationship-centered interventions over mere process optimization for better health and cost outcomes.
Leaders from West Virginia-based Hawse Health report progress after implementing AI‑assisted documentation
This issue brief provides data on immigrants’ role in the U.S. health care workforce, including within key industries such as direct long-term care and the hospital workforce.
These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road. The post What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures appeared first on MedCity News.